BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20211115T172159Z DESCRIPTION:Dr. Pamela Habib\, M.D.\, a Radiologist and Head of US Medical Affairs for Bayer Radiology\, will moderate a discussion with Dr. Leland S . Hu\, M.D.\, specific to the value of Dynamic Susceptibility Contrast (DS C)-MRI based Perfusion Weighted Imaging (PWI) in assisting radiologists in differentiating recurrent high-grade glioma vs. post-treatment effect. PW I using the DSC-MRI method is a very effective tool in evaluating gliomas\ , specifically glioblastomas\, which are the most common. Discussion will include the importance of technical acquisition considerations (e.g\,. pul se sequence parameters\, iv catheter placement\, etc). in achieving diagno stic quality. \n \nFor more on the session\, please visit: https://rsna202 1.rsna.org/live-stream/23144295/The-Value-of-MR-Perfusion-in-the-Diagnosis -and-Follow-up-of-Gliomas-Bayer \n \nRSNA registration is necessary whether virtual or in-person. Ple ase check official RSNA 2021 program for updates.\n \n DTEND;TZID="Central Standard Time":20211130T110000 DTSTAMP:20211115T172159Z DTSTART;TZID="Central Standard Time":20211130T103000 LAST-MODIFIED:20211115T172159Z LOCATION:https://intouchsol.zoom.us/j/99679583784 PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Bayer Virtual Theater Presentation | The Value of MR Perfusion in the Diagnosis and Follow up of Gliomas TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000B020D2480CC0D701000000000000000 0100000009A02293AC08FE944A8AD9461512F427A X-ALT-DESC;FMTTYPE=text/html:

Dr . Pamela Habib\, M.D.\, a Radiologist and Head of US Medical Affairs for B ayer Radiology\, will moderate a discussion with Dr. Leland S. Hu\, M.D.\, specific to the value of Dynamic Susceptibility Contrast (DSC)-MRI based Perfusion Weighted Imaging (PWI) in assisting radiologists in differentiat ing recurrent high-grade glioma vs. post-treatment effect. PWI using the D SC-MRI method is a very effective tool in evaluating gliomas\, specificall y glioblastomas\, which are the most common. Discussion will include the i mportance of technical acquisition considerations (e.g< /span>\,. pulse sequence parameters\, iv catheter placement\, etc). in achieving diagnostic quality.

 \;

For more on the session\, please visit: < a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__nam02.safelin ks.protection.outlook.com_-3Furl-3Dhttps-253A-252F-252Frsna2021.rsna.org-2 52Flive-2Dstream-252F23144295-252FThe-2DValue-2Dof-2DMR-2DPerfusion-2Din-2 Dthe-2DDiagnosis-2Dand-2DFollow-2Dup-2Dof-2DGliomas-2DBayer-26data-3D04-25 7C01-257Clhammond-2540rsna.org-257C6045fcb683014a23e2d008d9a3be4477-257Cfb 5fefcd7ca642f3b443917c2a68cecd-257C1-257C0-257C637720859872055079-257CUnkn own-257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLC JXVCI6Mn0-253D-257C1000-26sdata-3DaijozmpjT-252Bqk-252Bj9EYEzjozDD6PklV-25 2Fy0clCziA8KxMo-253D-26reserved-3D0&\;d=DwMFAw&\;c=OxmPmEcXpM2_mZU2Y Lv2srzCxuSHLcOxzx93sLQ5Tnc&\;r=MNXlQHjBrK6eUpDGQLOsjAOLOp_0z6BxILZhi-8l asES-dBGpdVoXebOhbQI2rmf&\;m=Lqc8iI-bfTMSbsgZ9DYFWBa880plPycQ64VFbbzs3a TV_5HNh5TjOv5oTBNwb1zk&\;s=Z4-ZaurhXlYFGuE-TsgiNaMAzdVDPLkoFHayM5ENAtQ& amp\;e=">https://rsna2021.rsna.org/live-stream/23144295/The-Value-of-MR-Pe rfusion-in-the-Diagnosis-and-Follow-up-of-Gliomas-Bayer

&nbs p\;

RSNA registration is necessary whether virtual or in-person. Please che ck official RSNA 202 1 program for updates.

&n bsp\;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR